SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Elliott Associates, L.P. – ‘4’ for 4/30/00 re: Vion Pharmaceuticals Inc.

As of:  Tuesday, 5/9/00   ·   For:  4/30/00   ·   Accession #:  1013594-0-118   ·   File #:  0-26534

Previous ‘4’:  ‘4’ on 4/10/00 for 3/31/00   ·   Next:  ‘4’ on 5/25/00 for 4/30/00   ·   Latest:  ‘4’ on 12/13/19 for 12/6/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/00  Elliott Associates LP             4          10% Owner   1:5K   Vion Pharmaceuticals Inc.         Kleinberg Kaplan Wo… P C

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of        4      9K 
                Securities by an Insider                                         

41st Page of 4TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) FORM 4 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 1. Name and Address of Reporting Person Elliott Associates, L.P. 712 Fifth Avenue New York, New York 10019 2. Issuer Name and Ticker Trading Symbol Vion Pharmaceuticals, Inc. (VION) 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for (Month/Day/Year) 04/00 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [ ] Officer (give title below) [ ] Chairman [x] 10% Owner [ ] Other (specify below) 7. Individual or Joint/Group Filing (Check applicable line) [x] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person (Page 1 of 4)
42nd Page of 4TOC1stPreviousNextBottomJust 2nd
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) Common Stock 2. Transaction Date (Month/Day/Year) 04/13/00 3. Transaction Code (Inst. 8) X V 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Amount: 78,132 (A) or (D): A Price: $6.23 5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4) 1,294,944 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) D 7. Nature of Indirect Beneficial Ownership (Instr. 4) Not applicable. Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Page 2 of 4)
43rd Page of 4TOC1stPreviousNextBottomJust 3rd
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g. puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) Class B Warrants 2. Conversion or Exercisable Price of Derivative Security $6.23 3. Transaction Date (Month/Day/Year) 04/13/00 4. Transaction Code (Instr. 8) Code X V 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) (A) (D) 78,132 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable: Currently Expiration Date: 08/13/00 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title: Common Stock Amount: 78,132 8. Price of Derivative Security (Inst. 5) * 9. Number of Derivative Securities Beneficially Owned at End of Month (Instr. 4) 0 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) D (Page 3 of 4)
4Last Page of 4TOC1stPreviousNextBottomJust 4th
11. Nature of Indirect Beneficial Ownership (Instr. 4) Not applicable. Explanation of Responses: *The Class B Warrants (along with shares of Common Stock) were obtained through the exercise of Class A Warrants at an exercise price of $4.63. **Intentional misstatement or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). ELLIOTT ASSOCIATES, L.P. By: Elliott Capital Advisors, L.P., as general partner By: Braxton Associates, Inc., as general partner By: /s/ Elliot Greenberg May 9, 2000 -------------------------------------------------------------------- Elliot Greenberg, Vice President Date **Signature of Reporting Person (Page 4 of 4)

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘4’ Filing    Date First  Last      Other Filings
Filed on:5/9/0043,  SC 13D/A
For Period end:4/30/004
 List all Filings 
Top
Filing Submission 0001013594-00-000118   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 10:43:37.2pm ET